Source: Cancer Research. Conference titles: Annual CTRC-AACR San Antonio Breast Cancer Symposium. Unidade: FM
Subjects: PLACEBO, NEOPLASIAS MAMÁRIAS (FISIOPATOLOGIA), ESTUDOS RANDOMIZADOS
ABNT
HURVITZ, Sara A. et al. Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS14-S6-01. Acesso em: 31 out. 2024. , 2015APA
Hurvitz, S. A., Andre, F., Jiang, Z., Shao, Z., Neciosup, S. P., Mano, M. S., et al. (2015). Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS14-S6-01NLM
Hurvitz SA, Andre F, Jiang Z, Shao Z, Neciosup SP, Mano MS, Tseng L-M, Zhang Q, Shen K, Liu D, Dreosti LM, Feng J, Burris HA, Toi M, Buyse ME, Cabaribere D, Lindsay M-A, Kunz T, Rao S, Pacaud LB, Taran T, Slamon D. Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1 [Internet]. Cancer Research. 2015 ; 75[citado 2024 out. 31 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-S6-01Vancouver
Hurvitz SA, Andre F, Jiang Z, Shao Z, Neciosup SP, Mano MS, Tseng L-M, Zhang Q, Shen K, Liu D, Dreosti LM, Feng J, Burris HA, Toi M, Buyse ME, Cabaribere D, Lindsay M-A, Kunz T, Rao S, Pacaud LB, Taran T, Slamon D. Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1 [Internet]. Cancer Research. 2015 ; 75[citado 2024 out. 31 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-S6-01